Vitamin D: a new hope for chronic kidney disease? (Q37641029)

21 August 2017

1 reference

title

Vitamin D: a new hope for chronic kidney disease? (English)

1 reference

21 August 2017

0 references

0 references

Vecihi Batuman

2

0 references

author name string

Min Li

series ordinal

1

1 reference

PubMed ID

19946310

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

76

1 reference

21 August 2017

12

1 reference

21 August 2017

1219-1221

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.390

21 August 2017

0 references

cites work

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Potential role of active vitamin D in retarding the progression of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Renoprotective role of the vitamin D receptor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Direct renin inhibition with aliskiren in hypertension and target organ damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.390

7 January 2021

Identifiers

DOI

10.1038/KI.2009.390

1 reference

21 August 2017

1 reference

PubMed ID

19946310